DNA METHYLATION MARKERS FOR METASTATIC PROSTATE CANCER
    3.
    发明申请
    DNA METHYLATION MARKERS FOR METASTATIC PROSTATE CANCER 审中-公开
    用于分子前列腺癌的DNA甲基标记物

    公开(公告)号:US20140274767A1

    公开(公告)日:2014-09-18

    申请号:US14162180

    申请日:2014-01-23

    IPC分类号: C12Q1/68

    摘要: The present invention relates to the field of cancer. More specifically, the present invention provides methods and compositions useful for assessing prostate cancer. In a specific embodiment, present inventors have developed and applied a new technology and associated computation methods enabling simultaneous genome-scale analysis of genetic (copy number) and epigenetic (total methylation (TM) and allele-specific methylation (ASM) alternation, This method, called MBD-SNP, features affinity enrichment or methylated genomic DNA fragments using a methyl-binding domain polypeptide.

    摘要翻译: 本发明涉及癌症领域。 更具体地,本发明提供了可用于评估前列腺癌的方法和组合物。 在一个具体的实施方案中,本发明人已经开发并应用了一种能够同时进行基因组(拷贝数)和表观遗传学(总甲基化(TM))和等位基因特异性甲基化(ASM)交替的基因组大规模分析的新技术和相关计算方法。 称为MBD-SNP,使用甲基结合结构域多肽具有亲和力富集或甲基化基因组DNA片段。